关注
Tomas Olsson
Tomas Olsson
未知所在单位机构
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
30162011
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
13502013
Randomized trial of oral teriflunomide for relapsing multiple sclerosis
P O'Connor, JS Wolinsky, C Confavreux, G Comi, L Kappos, TP Olsson, ...
New England Journal of Medicine 365 (14), 1293-1303, 2011
12752011
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
T Olsson, LF Barcellos, L Alfredsson
Nature Reviews Neurology 13 (1), 25-36, 2017
12422017
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
B Kornek, MK Storch, R Weissert, E Wallstroem, A Stefferl, T Olsson, ...
The American journal of pathology 157 (1), 267-276, 2000
12042000
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
9882018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ...
Multiple Sclerosis Journal 24 (2), 96-120, 2018
9332018
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
9302019
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ...
Nature genetics 53 (6), 817-829, 2021
8492021
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice
JC Souberbielle, JJ Body, JM Lappe, M Plebani, Y Shoenfeld, TJ Wang, ...
Autoimmunity reviews 9 (11), 709-715, 2010
7852010
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
C Confavreux, P O'Connor, G Comi, MS Freedman, AE Miller, TP Olsson, ...
The Lancet Neurology 13 (3), 247-256, 2014
6862014
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
MK Storch, A Stefferl, U Brehm, R Weissert, E Wallström, ...
Brain Pathology 8 (4), 681-694, 1998
6401998
Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis
F Lundmark, K Duvefelt, E Iacobaeus, I Kockum, E Wallström, M Khademi, ...
Nature genetics 39 (9), 1108-1113, 2007
6252007
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
5812019
Neurofascin as a novel target for autoantibody-mediated axonal injury
EK Mathey, T Derfuss, MK Storch, KR Williams, K Hales, DR Woolley, ...
The Journal of experimental medicine 204 (10), 2363-2372, 2007
4982007
Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
T Olsson, WW Zhi, B Höjeberg, V Kostulas, YP Jiang, G Anderson, ...
The Journal of clinical investigation 86 (3), 981-985, 1990
4631990
Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies
G Luna, P Alping, J Burman, K Fink, A Fogdell-Hahn, M Gunnarsson, ...
JAMA neurology 77 (2), 184-191, 2020
4442020
Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis
I Jelcic, F Al Nimer, J Wang, V Lentsch, R Planas, I Jelcic, A Madjovski, ...
Cell 175 (1), 85-100. e23, 2018
4442018
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women
AK Hedström, T Olsson, L Alfredsson
Multiple Sclerosis Journal 18 (9), 1334-1336, 2012
4392012
Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder
O Hansson, S Janelidze, S Hall, N Magdalinou, AJ Lees, U Andreasson, ...
Neurology 88 (10), 930-937, 2017
4242017
系统目前无法执行此操作,请稍后再试。
文章 1–20